Valion Bio, Inc. · NASDAQ:VBIO
3i, LP reported a 9.90% stake in Valion Bio, Inc. (Schedule 13D)
Event Jul 28, 2026 · Filed Aug 3, 2026
3i, LP reported a 9.90% stake in Valion Bio, Inc., 446,759 shares, with active intent on Jul 28, 2026. Filed Aug 3, 2026 (Schedule 13D).
- Stake
- 9.90%
- Shares
- 446,759
- Intent
- Active
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| 3i, LP | 9.90% | 446,759 |
| Tumim Stone Capital, LLC | 1.10% | 49,242 |
| 3i Management LLC | 9.90% | 441,294 |
| Maier J. Tarlow | 9.90% | 441,294 |
Source
Related
- Valion Bio, Inc.
- 3i, LP
- Valion Bio, Inc. shareholders
- Schedule 13D/A · 3i, LP · Aug 27, 2026
- Schedule 13D/A · 3i, LP · Aug 24, 2026
- Schedule 13D/A · 3i, LP · Aug 19, 2026
- Schedule 13D/A · 3i, LP · Aug 14, 2026
- Schedule 13D/A · 3i, LP · Aug 11, 2026
- Form 4 · Wolf Lisa G · Sep 24, 2026
- Schedule 13G · Murchinson Ltd. · Jul 17, 2026
- Form 4 · Wolf Lisa G · Jun 18, 2026
- Form 4 · Handley Michael K · May 20, 2026
- Schedule 13G/A · 3i, LP · May 8, 2026